Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ERBB3 Produits

(Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))

Catégories

This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized. [provided by RefSeq, Jul 2008].

antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.

Catégories ERBB3 en vedette

ERBB3 Anticorps

High quality antibodies with extensive validation data.

ERBB3 Kits ELISA

Reliable ELISA kits for a wide range of species.

ERBB3 Protéines

Proteins for various applications incl. WB, ELISA, IF etc.

ERBB3 recommandé Anticorps

Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity Mouse
Application WB, IHC, IP, ICC
Validations
  • (6)
N° du produit ABIN7440773
Quantité 100 μL
Fiche technique Fiche technique
Reactivity Human, Mouse
Application WB, IHC (p), FACS
Validations
  • (4)
  • (5)
N° du produit ABIN391949
Quantité 400 μL
Fiche technique Fiche technique
Reactivity Human, Mouse, Rat
Application WB, ELISA, IHC (p), IF (p), IF (cc), IHC (fro)
Validations
  • (4)
N° du produit ABIN747113
Quantité 100 μL
Fiche technique Fiche technique

ERBB3 recommandé Kits ELISA

Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Analytical Method Semi-Quantitative Sandwich ELISA
Validations
  • (3)
N° du produit ABIN1981720
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Human
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
N° du produit ABIN6959065
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Mouse
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
N° du produit ABIN6959066
Quantité 96 tests
Fiche technique Fiche technique

ERBB3 recommandé Protéines

Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Source HEK-293 Cells
Validations
  • (5)
N° du produit ABIN7274801
Quantité 100 μg
Fiche technique Fiche technique
Reactivity Human
Source HEK-293 Cells
Validations
  • (3)
N° du produit ABIN7274797
Quantité 100 μg
Fiche technique Fiche technique
Reactivity Cynomolgus, Rhesus Monkey
Source HEK-293 Cells
Validations
  • (3)
N° du produit ABIN7274795
Quantité 100 μg
Fiche technique Fiche technique

Dernières publications sur nos produits ERBB3

DAgostino, Gentile, Ponziani, Di Vittorio, Dituri, Giannelli, Rossi, Marzullo, Giansanti, De Laurenzi, Iacobelli, Ippoliti, Capone, Sala: "EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer." dans: Oncology reports, Vol. 45, Issue 2, pp. 776-785, (2021) (PubMed).

Shinozaki, Hashimoto, Fukui, Uchiyama: "Efficient generation of single domain antibodies with high affinities and enhanced thermal stabilities." dans: Scientific reports, Vol. 7, Issue 1, pp. 5794, (2019) (PubMed).

Capone, Lamolinara, DAgostino, Rossi, De Laurenzi, Iezzi, Iacobelli, Sala: "EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma." dans: Journal of controlled release : official journal of the Controlled Release Society, Vol. 277, pp. 48-56, (2019) (PubMed).

Memon, Gilliver, Borre, Sundquist, Sundquist, Nexo, Sorensen: "Soluble HER3 predicts survival in bladder cancer patients." dans: Oncology letters, Vol. 15, Issue 2, pp. 1783-1788, (2018) (PubMed).

Cao, Chen, Chen, Xiong: "Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients." dans: BMC cancer, Vol. 17, Issue 1, pp. 841, (2018) (PubMed).

Zomerman, Plasschaert, Diks, Lourens, Meeuwsen-de Boer, Hoving, den Dunnen, de Bont: "Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines." dans: PLoS ONE, Vol. 10, Issue 10, pp. e0141381, (2015) (PubMed).

Blair, Wu, Zahari, Mohseni, Cidado, Wong, Beaver, Cochran, Zabransky, Croessmann, Chu, Toro, Cravero, Pandey, Park: "A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations." dans: Proteomics, Vol. 15, Issue 2-3, pp. 318-26, (2015) (PubMed).

Zabransky, Yankaskas, Cochran, Wong, Croessmann, Chu, Kavuri, Red Brewer, Rosen, Dalton, Cimino-Mathews, Cravero, Button, Kyker-Snowman, Cidado, Erlanger, Parsons, Manto, Bose, Lauring, Arteaga et al.: "HER2 missense mutations have distinct effects on oncogenic signaling and migration. ..." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, Issue 45, pp. E6205-14, (2015) (PubMed).

Yan, Hein, Greer, Wang, Kolb, Batra, Cowan: "A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation." dans: Oncogene, Vol. 34, Issue 17, pp. 2215-26, (2015) (PubMed).

Liu, Leng, Gunasekaran, Pentony, Shen, Howard, Stoops, Manchulenko, Razinkov, Liu, Fanslow, Hu, Sun, Hasegawa, Clark, Foltz, Yan: "A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism." dans: The Journal of biological chemistry, (2015) (PubMed).

Synonymes et noms alternatifs relatifs à ERBB3

erb-b2 receptor tyrosine kinase 3 (ERBB3), v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (ERBB3), erb-b2 receptor tyrosine kinase 3 (Erbb3), c-erbB-3, c-erbB3, C76256, ErbB-3, Erbb-3, ERBB3, erbB3-S, Erbb3r, HER3, Her3, LCCS2, MDA-BF-1, nuc-ErbB3, p45-sErbB3, p85-sErbB3, p180-ErbB3

Protein level used designations for ERBB3

  • proto-oncogene-like protein c-ErbB-3
  • receptor tyrosine-protein kinase erbB-3
  • tyrosine kinase-type cell surface receptor HER3
  • v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
  • receptor tyrosine kinase ErbB3
  • receptor tyrosine-protein kinase erbB-3-like
  • avian erythroblastosis oncogene B 3 receptor
  • c-erbB-3
  • glial growth factor receptor
  • receptor tyrosine kinase
  • avian erythroblastosis oncogene B 3
  • c-erbB3
  • v-erb-b2 erythroblastic leukemia viral oncogene homolog 3
  • v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3
Vous êtes ici:
Support technique